ATE536874T1 - Dreifache monoamin-wiederaufnahmehemmer zur behandlung von chronischen schmerzen - Google Patents

Dreifache monoamin-wiederaufnahmehemmer zur behandlung von chronischen schmerzen

Info

Publication number
ATE536874T1
ATE536874T1 AT03724899T AT03724899T ATE536874T1 AT E536874 T1 ATE536874 T1 AT E536874T1 AT 03724899 T AT03724899 T AT 03724899T AT 03724899 T AT03724899 T AT 03724899T AT E536874 T1 ATE536874 T1 AT E536874T1
Authority
AT
Austria
Prior art keywords
treatment
inhibitors
chronic pain
reuppost
triple monoamine
Prior art date
Application number
AT03724899T
Other languages
English (en)
Inventor
Jorgen Scheel-Krueger
Gordon Blackburn-Munro
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Application granted granted Critical
Publication of ATE536874T1 publication Critical patent/ATE536874T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, ***e
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AT03724899T 2002-05-30 2003-05-27 Dreifache monoamin-wiederaufnahmehemmer zur behandlung von chronischen schmerzen ATE536874T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200200832 2002-05-30
PCT/DK2003/000352 WO2003101453A1 (en) 2002-05-30 2003-05-27 Triple monoamine reuptake inhibitors for the treatment of chronic pain

Publications (1)

Publication Number Publication Date
ATE536874T1 true ATE536874T1 (de) 2011-12-15

Family

ID=29594978

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03724899T ATE536874T1 (de) 2002-05-30 2003-05-27 Dreifache monoamin-wiederaufnahmehemmer zur behandlung von chronischen schmerzen

Country Status (11)

Country Link
US (1) US7459464B2 (de)
EP (1) EP1513529B1 (de)
JP (1) JP2005531594A (de)
CN (2) CN101444509A (de)
AT (1) ATE536874T1 (de)
AU (1) AU2003227520B9 (de)
CA (1) CA2484482C (de)
DK (1) DK1513529T3 (de)
MX (1) MXPA04011859A (de)
NZ (1) NZ536415A (de)
WO (1) WO2003101453A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ547880A (en) * 2003-11-18 2010-02-26 Boehringer Ingelheim Int Solid pharmaceutical preparation form
EP1904069B1 (de) 2005-07-15 2018-06-13 Albany Molecular Research, Inc. Aryl- und heteroarylsubstituierte tetrahydrobenzazepine und verwendung damit zur wiederaufnahmeblockierung von norepinephrin, dopamin und serotonin
EP1779851A1 (de) * 2005-10-31 2007-05-02 Boehringer Ingelheim Pharma GmbH & Co.KG Behandlung von Diabetes
GB0703998D0 (en) * 2007-03-01 2007-04-11 Glaxo Group Ltd Novel salt
CA2760837C (en) 2009-05-12 2018-04-03 Albany Molecular Research, Inc. 7-([1,2,4]triazolo[1,5-.alpha.]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline and use thereof
CN102638982B (zh) 2009-05-12 2015-07-08 百时美施贵宝公司 (S)-7-([1,2,4]***并[1,5-a]吡啶-6-基)-4-(3,4-二氯苯基)-1,2,3,4-四氢异喹啉的晶型及其用途
EP2606049A4 (de) * 2010-08-17 2014-01-08 Albany Molecular Res Inc 2,5-methan- und 2,5-ethan-tetrahydrobenzazepin-derivate und ihre verwendung zur hemmung der wiederaufnahme von norepinephrin, dopamin und serotonin

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5936675A (ja) 1982-07-13 1984-02-28 サンド・アクチエンゲゼルシヤフト 二環性複素環式カルボン酸アザビシクロアルキルエステルまたはアミド
WO1994026274A1 (en) * 1993-05-18 1994-11-24 Wake Forest University Treatment process with biologically active tropane derivatives
ZA971525B (en) * 1996-02-22 1997-10-21 Neurosearch As Tropane derivatives, their preparation and use.
GB9617990D0 (en) * 1996-08-29 1996-10-09 Scotia Holdings Plc Treatment of pain
US6331571B1 (en) * 1998-08-24 2001-12-18 Sepracor, Inc. Methods of treating and preventing attention deficit disorders
US6323242B1 (en) 1998-12-02 2001-11-27 Peter Sterling Mueller Treatment of disorders secondary to organic impairments
US6803387B1 (en) * 1999-03-19 2004-10-12 Abbott Gmbh & Co. Kg Treatment of neuropathic pain or fibromyalgia
DE60022916T2 (de) * 1999-07-01 2006-07-06 Pharmacia & Upjohn Co. Llc, Kalamazoo Reboxetin zur Behandlung von peripheren Neuropathien
WO2002094827A1 (en) * 2001-05-23 2002-11-28 Neurosearch A/S Fused tropane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
WO2002102801A1 (en) * 2001-05-23 2002-12-27 Neurosearch A/S Tropane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors

Also Published As

Publication number Publication date
US20050239824A1 (en) 2005-10-27
CA2484482A1 (en) 2003-12-11
AU2003227520A1 (en) 2003-12-19
AU2003227520B2 (en) 2008-05-01
CN1655787A (zh) 2005-08-17
MXPA04011859A (es) 2005-03-31
CN101444509A (zh) 2009-06-03
JP2005531594A (ja) 2005-10-20
DK1513529T3 (da) 2012-03-26
US7459464B2 (en) 2008-12-02
CA2484482C (en) 2011-07-26
EP1513529A1 (de) 2005-03-16
AU2003227520B9 (en) 2008-06-26
EP1513529B1 (de) 2011-12-14
NZ536415A (en) 2006-10-27
WO2003101453A1 (en) 2003-12-11

Similar Documents

Publication Publication Date Title
NO20063064L (no) Ny anvendelse av peptidforbindelser for behandling av sentralneurotisk smerte
EA200601553A1 (ru) Замещенные бензимидазол-, бензтриазол- и бензимидазолон-о-глюкозиды
EA200601239A1 (ru) Замещённые хинолиновые соединения
MXPA05005223A (es) Diaminotriazoles utiles como inhibidores de proteinas cinasas.
DK1809280T3 (da) Mitotiske kinesininhibitorer og fremgangsmåder til anvendelse deraf
DE602004014117D1 (de) Thiazole zur verwendung als inhibitoren von protein-kinasen
EA201070247A1 (ru) Ингибиторы протеасом
EA200602221A1 (ru) Новое применение пептидных соединений для лечения боли при тригеминальной невралгии
HRP20050041B1 (hr) UPOTREBA INHIBITORA IκB KINAZE U TERAPIJI BOLOVA
NO20055741D0 (no) Nye kjemiske forbindelser
HUP0300117A2 (hu) Interleukin-6 antagonisták alkalmazása aromatáz magas szintjével jellemzett betegségek kezelésére
ATE497809T1 (de) Myricitrin verbindungen zur behandlung von schlafstörungen
NO20055563L (no) Midler for behandlingen av lavere abdominale lidelser
DE502004010131D1 (de) Pyridopyrimidinone zur behandlung von krebserkrankungen
SE0302304D0 (sv) Novel compounds
DE60329326D1 (de) Tace inhibitoren
MY136367A (en) Treatment of cognitive failure
ATE536874T1 (de) Dreifache monoamin-wiederaufnahmehemmer zur behandlung von chronischen schmerzen
NO20061425L (no) Kombinasjonen av en serotonin-reopptaksinbibitor og loxapin
DE602004019541D1 (de) Cycloalkyläbü kondensierte indole
DK1455770T3 (da) Anvendelse af norepinephringenoptagelsesinhibitorer til behandling af tic lidelser
ATE392212T1 (de) Verwendung eines proteasom-inhibitors zur behandlung fibrotischer erkrankungen
UA87117C2 (ru) Применение пептидных соединений для лечения центральной невропатической боли
DE50308460D1 (de) Verwendung von ambroxol zur behandlung von chronischen schmerzen
DE60326348D1 (de) Makrozyclen zur behandlung von krebserkrankungen